MODIFICATION OF CORNEAL TISSUE ENGINEERED SCAFFOLDS TO PROMOTE EPITHELIALIZATION

改良角膜组织工程支架以促进上皮化

基本信息

  • 批准号:
    7609944
  • 负责人:
  • 金额:
    $ 2.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Attempts to augment and replace the cornea with synthetic materials have met with limited succeass, primarily because these devices have been unable to support and maintain a normal stratified epithelium. The fundamental problem is that the host epithelial cells recognize the polymer surface as other than stroma or "self" and, therefore, a degree of foreign body response is present throughout the life of the implant. Although natural materials often have good biocompatibility, they lack the strength to support tissue regeneration and the ability to withstand the natural wound remodeling process. It is advantageous, therefore, to consider combination strategies for leveraging the advantages of synthetic and natural materials for tissue engineering applications. For corneal material construction, a minimum 2-layer microstructured scaffold is specifically required to separate the epithelial layer from the stromal cell layer. The central part of the scaffold material must support infiltration and growth of stromal cells, whereas the outer surface of the scaffold must allow the adhesion and maintenance of the epithelial layer. Extracellular matrix proteins (ECMPs) and peptides covalently tethered to the scaffold surfaces are also needed to enhance cell growth. We propose to integrate novel chemistry, micro/nanofabrication, and cell biology methods to first understand and then control corneal both epithelial and stromal cell-material interactions as a method to engineer an effective corneal replacement/augmentation material. Our specific aims are as follows: Specific Aim I: To develop and characterize 3-dimensional scaffolds of silicone hydrogels, collagen, and chitosan (and/or copolymers thereof), as the framework for an optimal corneal replacement/augmentation material. Specific Aim II: To increase optimal cellular response to the developed polymer scaffold materials by modifying their surfaces with tethered ECMPs and peptides using novel micro/nanofabrication techniques. Specific Aim III: To quantify and analyze the cellular response to the developed polymer scaffolds using primary rabbit epithelial and keratocyte cell culture and corneal organ culture.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 用合成材料增加和替换角膜的尝试遇到了有限的困难,主要是因为这些装置不能支持和维持正常的复层上皮。基本问题是宿主上皮细胞将聚合物表面识别为不同于基质或“自身”,因此,在植入物的整个寿命期间存在一定程度的异物反应。尽管天然材料通常具有良好的生物相容性,但它们缺乏支持组织再生的强度和承受自然伤口重塑过程的能力。因此,考虑利用合成和天然材料的优点用于组织工程应用的组合策略是有利的。对于角膜材料构建,特别需要最少2层微结构化支架以将上皮层与基质细胞层分离。支架材料的中心部分必须支持基质细胞的浸润和生长,而支架的外表面必须允许上皮层的粘附和维持。也需要共价连接到支架表面的细胞外基质蛋白(ECMP)和肽来增强细胞生长。我们建议整合新的化学,微/纳米纤维和细胞生物学方法,首先了解,然后控制角膜上皮和基质细胞材料的相互作用,作为一种方法来设计一种有效的角膜替代/增强材料。我们的具体目标如下: 具体目标一:开发和表征硅胶水凝胶、胶原蛋白和壳聚糖(和/或其共聚物)的三维支架,作为最佳角膜置换/增强材料的框架。 具体目标二:为了增加最佳的细胞反应,开发的聚合物支架材料,通过修改其表面与栓系的ECMPs和肽,使用新的微/纳米纤维技术。 具体目标三:使用原代兔上皮细胞和角膜细胞培养物以及角膜器官培养物定量和分析对开发的聚合物支架的细胞反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Huiguang Zhu其他文献

Huiguang Zhu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Huiguang Zhu', 18)}}的其他基金

MODIFICATION OF CORNEAL TISSUE ENGINEERED SCAFFOLDS TO PROMOTE EPITHELIALIZATION
改良角膜组织工程支架以促进上皮化
  • 批准号:
    7381342
  • 财政年份:
    2006
  • 资助金额:
    $ 2.71万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 2.71万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 2.71万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 2.71万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 2.71万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 2.71万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 2.71万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 2.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了